BlackRock Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $243K | Buy |
28,025
+2,751
| +11% | +$23.9K | ﹤0.01% | 2597 |
|
|
2016
Q3 | $161K | Buy |
25,274
+1,179
| +5% | +$7.51K | ﹤0.01% | 2682 |
|
|
2016
Q2 | $102K | Sell |
24,095
-394
| -2% | -$1.67K | ﹤0.01% | 2778 |
|
|
2016
Q1 | $106K | Buy |
24,489
+9,039
| +59% | +$39.1K | ﹤0.01% | 2733 |
|
|
2015
Q4 | $95K | Sell |
15,450
-525
| -3% | -$3.23K | ﹤0.01% | 2688 |
|
|
2015
Q3 | $91K | Buy |
15,975
+3,808
| +31% | +$21.7K | ﹤0.01% | 2712 |
|
|
2015
Q2 | $91K | Buy |
+12,167
| New | +$91K | ﹤0.01% | 2756 |
|